Suchergebnisse - (Person:"Thaventhiran, James")

PubPharm (103)

31

Accelerated waning of the humoral response to SARS-CoV-2 vaccines in obesity

enthalten in: bioRxiv.org | 2022

von van der Klaauw, A. | Horner, E. | Pereyra-Gerber, P. | +38

32

A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2022

von Gerber, P. | Duncan, L. | Greenwood, E. | +13

33

Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma

enthalten in: Blood | 2022

von Anderson, G. | Ballester-Beltran, J. | Giotopoulos, G. | +25

CommentIn: Blood. 2022 Apr 21;139(16):2417-2418. - PMID 35446380

34

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

enthalten in: Journal of clinical immunology | 2022

von Shields, A. | Faustini, S. | Hill, H. | +22

35

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

enthalten in: Journal of clinical immunology | 2022

von Shields, A. | Faustini, S. | Hill, H. | +22

36

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

enthalten in: Journal of clinical immunology | 2022

von Shields, A. | Faustini, S. | Hill, H. | +22

37

Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study

enthalten in: ResearchSquare.com | 2022

von Shields, A. | Faustini, S. | Hill, H. | +25

38

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

enthalten in: Nature | 2022

von Meng, B. | Abdullahi, A. | Ferreira, I. | +154

UpdateOf: Res Sq. 2022 Jan 17;:. - PMID 35075452

39

A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection

enthalten in: PLoS pathogens | 2022

von Gerber, P. | Duncan, L. | Greenwood, E. | +13

40

Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation : An Update From the COV-AD Study

enthalten in: Frontiers in immunology | 2022

von Shields, A. | Faustini, S. | Hill, H. | +64